NEWS
RESOURCES
PODCAST
Donate
Subscribe
Search

Medication Subsidy (PBAC), Medications and Treatments, Disease Modifying Therapy, DMT, Pharmaceutical Benefits Advisory Committee, PBAC

MS Australia
registered charity

Let's connect

Newsletter subscribe
Facebook-f Twitter Linkedin-in Youtube Spotify

Participate in MS Research

Quick links

© 2024 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT
Read More
Joint Standing Committee on the NDIS inquiry into the future of the NDIS
Submission to the Australian National Audit Office’s performance audit of the Australian Government Department of Health’s management of the expansion of telehealth services in response to the COVID-19 pandemic

Newsletter subscription

  • Enter your details

Glatiramer acetate (Copaxone®) in the form of a pre-filled pen to PBAC, March 2022